Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

502
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
502
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

394
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
394
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

782
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
782
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

704
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
704
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

1.3K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.3K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

1.0K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Accuracy of Toric Intraocular Lens Formulas in Eyes With Previous Myopic Laser Vision Correction.

Journal of refractive surgery (Thorofare, N.J. : 1995)·2026
Same author

A case of carbapenamase production in <i>Shigella flexneri</i> isolated in Ireland, 2025.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same author

Steroid-Refractory Warm Autoimmune Haemolytic Anaemia Complicating Ulcerative Colitis in Pregnancy: A Case Report and Management Considerations.

Cureus·2026
Same author

Predicting the Risk of Decompensation in Patients With Cirrhosis: A Validated Machine Learning Approach.

The American journal of gastroenterology·2026
Same author

Inpatient and post-discharge thromboembolic events in inflammatory bowel disease patients: a 13 year retrospective cohort study at a tertiary Centre.

Scandinavian journal of gastroenterology·2026
Same author

Quality metrics reflecting patient experience of gastrointestinal endoscopy in inflammatory bowel disease: results of national endoscopy dataset analysis.

Journal of Crohn's & colitis·2026

相关实验视频

Updated: Jan 6, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.4K

重新评估胃潰瘍重估:在19年的回顧性對照研究中,低惡性病發率和高成本.

Thomas Matthews1, Mark Vesey2,3, Aditya Billur3

  • 1Department of Gastroenterology, Mater Misericordiae University Hospital, Dublin, Ireland. thomasmatthews@mater.ie.

Journal of gastrointestinal cancer
|December 1, 2025
PubMed
概括

具有良性特征和适当组织学的胃 (GUs) 的例行重新评估提供了最小的益处,并产生了高成本. 针对可疑的选择性方法在胃癌检测和资源分配方面更有效.

关键词:
活检是为了检查生物质.胃镜检查 (Gastroscopy) 是一种检查.医疗保健成本 医疗保健成本胃的新生瘤 胃的新生瘤胃潰瘍是一種胃潰瘍.

更多相关视频

Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care
05:50

Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care

Published on: September 22, 2023

4.1K
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

6.0K

相关实验视频

Last Updated: Jan 6, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.4K
Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care
05:50

Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care

Published on: September 22, 2023

4.1K
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

6.0K

科学领域:

  • 胃肠病学 胃肠病学
  • 在瘤学瘤学.
  • 卫生经济学 卫生经济学

背景情况:

  • 胃的常规内镜再评估是排除恶性瘤的标准实践.
  • 普遍GU监测的必要性和成本效益越来越受到质疑,特别是在胃癌发病率低至中等的地区.

研究的目的:

  • 评估在GU中重复胃镜指南的遵守情况.
  • 为了确定恶性瘤的预测因素在GU.
  • 评估与GU重新评估相关的诊断产量和医疗保健成本.

主要方法:

  • 从56,874次胃镜 (2006年5月至2024年8月) 中对2132个指数GU进行了回顾性分析.
  • 收集的数据包括人口统计,内镜和组织学发现.
  • 恶性结局通过组织学数据库跟踪;逻辑回归确定恶性预测因素.

主要成果:

  • 胃恶性瘤在4% (86/2132) 的GU中被发现,96%在初始活检时被检测出来.
  • 宏观性关注是最强的恶性瘤预测因素 (OR 66.9),其次是年龄较大,男性性别和非腹腔位置.
  • 良性的常规监测没有导致癌症;重新评估成本超过100万欧元,占内镜工作负载的2.5%.

结论:

  • 常规重新评估良性GUs与适当的组织学提供最小的诊断价值和显著的成本.
  • 建议采用选择性监测策略,重点关注具有可疑特征的,不充分的活检或持续的症状.
  • 这种方法优化了资源分配,减少了不必要的内镜手术.